BioNexus Gene Lab CFO Wei Li Leong resigns effective Oct 30, 2023

BioNexus Gene Lab Corp

Wei Li Leong resigned as CFO effective October 30, 2023; will stay for one additional month.
Resignation not due to any disagreement with the company, management, or board.
Company to actively identify a replacement CFO; no successor named as of Nov 3, 2023.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Wei Li Leong

Chief Financial Officer

BGLC · BioNexus Gene Lab Corp

Effective: 2023-10-30
Filed: November 3, 2023, 7:59 PM ET

On October 30, 2023, Ms. Wei Li Leong, the Chief Financial Officer (“CFO”), tendered her resignation letter to BioNexus Gene Lab Corp. (the “Company”) from her position at the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Wei Li Leong resigned as Chief Financial Officer at BioNexus Gene Lab Corp.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On October 30, 2023, Ms. Wei Li Leong, the Chief Financial Officer (“CFO”), tendered her resignation letter to BioNexus Gene Lab Corp. (the “Company”) from her position at the Company.

View on SEC.gov

BioNexus Gene Lab Corp filing history →

Source: SEC EDGAR

accession 0001477932-23-008068

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.